CompletedNCT07432815
Treatment of Psoriasis With Depression and/or Anxiety With Methotrexate vs Combined Methotrexate and Antidepressant
Medication studyAges 18–60Egypt
Understand this study
Who was this study for?
Listed age limits: 18 years to 60 years.
- Listed locations
- CairoSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: February 1, 2026
- Recruitment status
- Completed
- Enrollment listed in the registry
- 40
- Sponsor
- Cairo University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Combination product, Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Egypt
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT07432815
- Official title
Show the full official title
Treatment of Psoriasis With Depression and/or Anxiety With Methotrexate vs Combined Methotrexate and Antidepressant, A Randomized Controlled Trial
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cairo
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Cairo University, a university.
Did this study involve medication?
Yes. The study involved medication, including Methotrexate.
Who was this study for?
Listed age limits: 18 years to 60 years.
